Señales en vivo de MYMD | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease...

Stats
Volumen de hoy	36 918.00
Volumen promedio	228 437
Capitalización de mercado	7.18M
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.620
ATR14	$0.0310 (0.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-24	Rivard Paul	Buy	150 000	Common stock
2023-08-17	Rivard Paul	Buy	25 000	Common stock
2023-06-07	Chapman Christopher C Jr	Buy	300 000	Employee Stock Option (Right to Buy)
2023-06-07	Kaplin Adam	Buy	150 000	Employee Stock Option (Right to Buy)
2023-06-07	Uzonwanne Jude	Buy	150 000	Employee Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 84 transactions
Buy: 8 636 568 \| Sell: 532 775

Volumen Correlación

Largo: 0.04 (neutral)

Corto: -0.26 (neutral)

Signal:(59.659) Neutral

MyMD Pharmaceuticals, Correlación

10 Correlaciones Más Positivas
TBLT	0.96
VRM	0.957
RIDE	0.956
FFIE	0.952
TENX	0.95
IRBT	0.948
CRCT	0.947
ENNV	0.947
OM	0.947
MSEX	0.947

10 Correlaciones Más Negativas
NVCN	-0.957
TIOA	-0.956
ADTH	-0.954
SILK	-0.953
MSDA	-0.952
VLAT	-0.952
ALOR	-0.948
TIOAU	-0.948
BRIVU	-0.946
BUFF	-0.944

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MyMD Pharmaceuticals, Correlación - Moneda/Commodity

0.44
( neutral )

0.30
( neutral )

0.00
( neutral )

0.35
( neutral )

0.71
( moderate )

0.07
( neutral )

MyMD Pharmaceuticals, Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.59

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.59

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-11.68

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.850

Financial Reports:

No articles found.

MyMD Pharmaceuticals,

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.